Letter: Overcoming Secondary Loss of Response to Infliximab-It Is Not the Drug, It Is How You Use It! Authors’ Reply
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14974
Full Text
Open PDFAbstract
Available in full text
Date
October 14, 2018
Authors
Publisher
Wiley